Antimycotic Azoles (all routes except local only) updated on 01-29-2025

Digestive system anomalies

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17833
R75263		 Berard - Fluconazole, 2019 Digestive malformations 1st trimester nested case control unexposed (general population or NOS) Adjustment: Yes Fluconazole not specified or mixed dose 1.13 [0.37;3.48] 5/1,313   620/225,286 625 1,313
ref
Total 1 studies 1.13 [0.37;3.47] 625 1,313
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Berard - Fluconazole, 2019Berard - Fluconazole, 2019 1.13[0.37; 3.48]6251,3130%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: lowROB mesure: criticalROB reporting: moderate0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0 case control studiescase control studies 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 1 Tags Adjustment   - Yes  - Yes 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 1 Fluconazole not specified or mixed doseFluconazole not specified or mixed dose 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 1 All studiesAll studies 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.13[0.37; 3.47]6251,313 -NABerard - Fluconazole, 2019 10.510.01.0